Inhibition of class IIa HDACs reduces mutant HTT aggregation by affecting RNA stability
IntroductionHuntington’s disease (HD) is a fatal inherited neurological disorder for which there are no curative treatments available. Patients suffer from progressive impairment in cognitive and motor functions. Transcriptional dysregulation is a major molecular disease mechanism of HD. Transcripti...
Saved in:
| Main Authors: | Annika Reisbitzer, Cecilia Hollitzer, Adriana Geraci, Jessye Schaefer, Maximilian Burghaus, Jonas Bruns, Joachim Urban, Thomas Kurz, Sybille Krauß |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-06-01
|
| Series: | Frontiers in Molecular Neuroscience |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fnmol.2025.1579194/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeted intervention of tumor microenvironment with HDAC inhibitors and their combination therapy strategies
by: Wanli Zhang, et al.
Published: (2025-02-01) -
Synthesis and biological evaluation of ortho-phenyl phenylhydroxamic acids containing phenothiazine with improved selectivity for class IIa histone deacetylases
by: Kai-Cheng Hsu, et al.
Published: (2024-12-01) -
UBL3 Interacts with PolyQ-Expanded Huntingtin Fragments and Modifies Their Intracellular Sorting
by: Soho Oyama, et al.
Published: (2024-10-01) -
Mechanisms of HDACs in cancer development
by: Ying Zhang, et al.
Published: (2025-04-01) -
CRISPR activation identifies a novel miR-2861 binding site that facilitates the osteogenesis of human mesenchymal stem cells
by: Seong-Ho Park, et al.
Published: (2024-11-01)